In any case, given the age and characteristics of the subjects, it does not seem reasonable to assume that these Tau levels are secondary to the fact that they also have tauopathy or Alzheimer's disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.